The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.

The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).

The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.

We are looking for a Postdoctoral Researcher with expertise in systems immunology and immune-repertoire analysis for the Cancer Immunogenomics group, led by Dr. Eduard Porta.

RESEARCH DESCRIPTION

Our research lies at the interface of artificial intelligence, molecular biology and medical oncology, and we bring together experts from all three fields. We use computational approaches to study the interaction between genetic variants in cancer genomes and multiple aspects of cancer, ranging from the immune response against tumors to the susceptibility of cancer cells to different treatments. This position will focus on integrating high-dimensional immune profiling, TCR-sequencing, single-cell and multi-omics data to understand tumor-immune interactions and clinically relevant immune responses.

MAIN RESPONSABILITIES

• Analyse and integrate bulk and single-cell TCR-seq, flow cytometry, NGS and other high-dimensional immune-profiling datasets.

• Develop reproducible R/Python pipelines for quality control, statistical modelling, visualisation, dashboards and reporting.

• Integrate immune-repertoire, genomic, transcriptomic and clinical data to study tumor-immune interactions and treatment response.

• Write scientific manuscripts and technical documentation; present results at national and international conferences.

WHAT WE NEED

• PhD in Immunology, Systems Immunology, Computational Biology, Bioinformatics, Biomedicine or a related field.

• Strong background in T-cell immunology, immune repertoire biology, vaccine/immunotherapy responses and/or cancer immunology.

• Experience with TCR-seq, single-cell immune profiling and/or NGS data analysis, including dataset quality control.

• Proficiency in R and/or Python for biostatistics, high-dimensional data analysis, visualisation and reproducible workflows.

• Experience with flow cytometry data analysis; experience with cell culture or patient-sample workflows is an asset.

• Knowledge of machine learning, graph theory, multi-omics integration or data mining is an asset.

• Familiarity with Linux/bash, Git/GitHub/GitLab, shared servers, SLURM, cloud or HPC environments.

• High level of motivation, proactivity, and interest in translational biomedical research.

• Ability to work independently, manage varying workloads and collaborate across computational, wet-lab and clinical teams.

• Excellent communication skills and good written/spoken English; Spanish/Catalan are assets.

WHAT WE OFFER

• Full time contract (1623 hours per year)

• Postdoctoral Researcher Contract

• Measures to promote work-life balance (flexible working hours, 23 working days of vacation, and personal leave).

• Flexible remuneration program (kindergarten and other measures).

• Training and development opportunities.

• Incorporation in a multinational and highly collaborative team.

• To work on high-impact cancer immunogenomics projects connecting computational and experimental immunology.

• Mixed basic, computational and clinical research environment of the Josep Carreras Leukaemia Research Institute.

• Competitive Salary to be further defined depending on candidate experience.

• The stimulating environment of the IJC and its scientific network.

DEADLINE

Please submit your application by July 15th 2026.

WHO WE ARE?

What makes us different?

The mission of the Josep Carreras Leukaemia Research Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on Leukaemia and other malignant blood diseases, with the aim of finding a cure for these diseases.

The IJC’s vision is to be a world-class reference and excellent research center that contributes to the improvement of results, and the cure of patients affected by leukaemia and other malignant haemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.

HR Excellence

In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The Board of Trustees is composed of representatives of the Generalitat de Catalunya (regional government), University of Barcelona, Autonomous University of Barcelona, the City of Badalona and the Jose Carreras International Leukaemia Foundation
The Catalan government provides hard money on an annual basis. The Jose Carreras International Leukaemia Foundation provides start-up funds, project funds as well as financial support for investments.
The JCI has an international scientific advisory board served by prominent researchers from US and Europe.
The IJC has been awarded ERC and other EU grants.

The IJC is an equal-opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.